Medicines momentum: Europe sets stage for improved clinical trials scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Healx co-founder and CEO Tim Guilliams is predicting a blockbusting 2024 for the Cambridge-based rare disease AI specialist following a major investment boost from the US.
/PRNewswire/ Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, today announced that it has signed.
NF affects one in every 2,000 people. All patients are born with it, but some don't show symptoms until they are young adults. For those patients, it can be hard to diagnose.